Chemical compositions and methods of synthesis thereof. The compositions disclosed and described herein are directed toward thyroid hormone a?ß3 integrin receptor antagonists conjugated to targets of the norepinephrine transporter (NET) or the catecholamine transporter. The compositions have a dual targeting effect and increased targeting efficiency in the treatment and diagnostic imaging of neuroendocrine tumors.